Systemic and microcirculatory effects of dobutamine in patients with septic shock

Journal of Critical Care

Volumn 27, Issue 6, 2012, Pages 630-638

  Enrico, Carolina ^a,b   Kanoore Edul, Vanina S ^a,b,c   Vazquez, Alejandro Risso ^a   Pein, María C ^a   Pérez de la Hoz, Ricardo A ^a   Ince, Can ^c   Dubin, Arnaldo ^a,b  

^a Sanatorio Otamendi y Miroli   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Dobutamine; Hypoperfusion; Microcirculation; Septic shock; Stroke volume

Indexed keywords

DOBUTAMINE; NORADRENALIN;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CLINICAL ARTICLE; CLINICAL EVALUATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FLUID RESUSCITATION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; OUTCOME ASSESSMENT; PREDICTION; SEPTIC SHOCK; SYSTOLIC DYSFUNCTION; TACHYCARDIA; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE; VASCULAR RESISTANCE;

ACID-BASE EQUILIBRIUM; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIOTONIC AGENTS; DOBUTAMINE; FEMALE; HEMODYNAMICS; HUMANS; LACTIC ACID; MALE; MICROCIRCULATION; MIDDLE AGED; MOUTH FLOOR; SHOCK, SEPTIC;

EID: 84870716047     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.08.002     Document Type: Article

References (30)

1. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008, 34:17-60.
2. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
3. Ruffolo R.R. Review: the pharmacology of dobutamine. Am J Med Sci 1987, 294:244-248.
4. Stoner J.D., Bolen J.L., Harrison D.C. Comparison of dobutamine and dopamine in treatment of severe heart failure. Br Heart J 1977, 39:536-539.
5. Dubin A., Murias G., Sottile J.P., et al. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 2007, 33:485-494.
6. Hayes M.A., Timmins A.C., Yau E.H., et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717-1722.
7. Jellema W.T., Groeneveld A.B., Wesseling K.H., et al. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock. Crit Care Med 2006, 34:2392-2398.
8. Kumar A., Schupp E., Bunnell E., et al. Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care 2008, 12:R35.
9. De Backer D., Creteur J., Dubois M.J., et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006, 34:403-408.
10. Hernandez G, Regueira T, Bruhn A, et al.:Effects of dobutamine on microcirculation, regional and peripheral perfusion in septic shock patients: a randomized double blind crossover trial. Preliminary report. Intensive Care Med37(Suppl1):S92:0346, 2011 (abstr).
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874.
12. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
13. Dobbe J.G., Streekstra G.J., Atasever B., et al. Measurement of functional microcirculatory geometry and velocity distributions using automated image analysis. Med Biol Eng Comput 2008, 46:659-670.
14. Kanoore Edul V.S., Enrico C., Laviolle B., et al. Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med 2012, 40:1443-1448.
15. Shoemaker W.C., Appel P.L., Kram H.B. Hemodynamic and oxygen transport effects of dobutamine in critically ill general surgical patients. Crit Care Med 1986, 14:1032-1037.
16. Vincent J.L., Roman A. Dobutamine administration in septic shock: addition to a standard protocol. Crit Care Med 1990, 18:689-693.
17. Hayes M.A., Timmins A.C., Yau E.H., et al. Oxygen transport patterns in patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit Care Med 1997, 25:926-936.
18. Gutierrez G., Clark C., Brown S.D., et al. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994, 150:324-329.
19. Hollenberg S.M., Ahrens T.S., Annane D., et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004, 32:1928-1948.
20. Jozwiak M., Persichini R., Monnet X., et al. Management of myocardial dysfunction in severe sepsis. Semin Respir Crit Care Med 2011, 32:206-214.
21. Elbers P.W., Ozdemir A., van Iterson M., et al. Microcirculatory imaging in cardiac anesthesia: ketanserin reduces blood pressure but not perfused capillary density. J Cardiothorac Vasc Anesth 2009, 23:95-101.
22. Dubin A., Pozo M.O., Casabella C.A., et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 2009, 13:R92.
23. Secchi A., Wellmann R., Martin E., et al. Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat. J Crit Care 1997, 12:137-141.
24. De Backer D., Zhang H., Manikis P., et al. Regional effects of dobutamine in endotoxic shock. J Surg Res 1996, 65:93-100.
25. Hiltebrand L.B., Krejci V., Sigurdsson G.H. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 2004, 100:1188-1197.
26. Nevière R., Mathieu D., Chagnon J.L., et al. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996, 154(6 Pt 1):1684-1688.
27. Lebuffe G., Levy B., Nevière R., et al. Dobutamine and gastric-to-arterial carbon dioxide gap in severe sepsis without shock. Intensive Care Med 2002, 28:265-271.
28. van Genderen M., Gommers D., Klijn E., et al. Postoperative sublingual microcirculatory derangement following esophagectomy is prevented with dobutamine. Clin Hemorheol Microcirc 2011, 48:275-283.
29. Bucher M., Kees F., Taeger K., Kurtz A. Cytokines down-regulate alpha1-adrenergic receptor expression during endotoxemia. Crit Care Med 2003, 31:566-571.
30. Kates R.E., Leier C.V. Dobutamine pharmacokinetics in severe heart failure. Clin Pharmacol Ther 1978, 24:537-541.